Ⅳ型膠原α1(COL4a1)多克隆抗體
Polyclonal Antibody to Collagen Type IV Alpha 1 (COL4a1)
COL4-A1; Arresten; Collagen Alpha-1(IV)chain
- 編號PAA149Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPA149Hu01-Ⅳ型膠原α1(COL4a1)重組蛋白
- 緩沖液成份磷酸鹽緩沖液(pH7.4,含有0.02% NaN3和50%甘油)
- 性狀液體
- 濃度0.5mg/mL
- 且適物種Mus musculus (Mouse,小鼠), Rattus norvegicus (Rat,大鼠)
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術(shù),請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 569 ¥ 1327 ¥ 1896 ¥ 4740 ¥ 18960
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對COL4a1的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別COL4a1。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APA149Hu01 | Ⅳ型膠原α1(COL4a1)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA149Hu01 | Ⅳ型膠原α1(COL4a1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA149Hu01 | Ⅳ型膠原α1(COL4a1)多克隆抗體 | WB; IHC; ICC; IP. |
LAA149Hu71 | Ⅳ型膠原α1(COL4a1)多克隆抗體(生物素標記) | WB; IHC; ICC. |
LAA149Hu81 | Ⅳ型膠原α1(COL4a1)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
MAA149Hu22 | Ⅳ型膠原α1(COL4a1)單克隆抗體 | WB; IHC; ICC; IP. |
MAA149Hu21 | Ⅳ型膠原α1(COL4a1)單克隆抗體 | WB; IHC; ICC; IP. |
SEA149Hu | Ⅳ型膠原α1(COL4a1)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA149Hu | Ⅳ型膠原α1(COL4a1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
Cancer Research | Peritoneal Dissemination Requires an Sp1-Dependent CXCR4/CXCL12 Signaling Axis and Extracellular Matrixa??Directed Spheroid Formation [Pubmed:26744523] |
PLoS One | miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes [10.1371] |
Journal of Diabetes & Metabolic Disorders | Endothelin-1 traps potently reduce pathologic markers back to basal levels in an in vitro model of diabetes [] |
Experimental and Molecular Pathology? | Epitope recognized by anti-glomerular basement membrane (GBM) antibody in a patient with repeated relapse of anti-GBM disease [Pubmed: 30817909] |
Journal of Diabetes & Metabolic Disorders | In vivo studies demonstrate that endothelin-1 traps are a potential therapy for type I diabetes [] |
Frontiers in Endocrinology | Curcumin Analogs Reduce Stress and Inflammation Indices in Experimental Models of Diabetes [Pubmed: 31920992] |
留言咨詢